What counts as a Symbicort alternative?
Symbicort is a brand-name inhaler that combines an inhaled corticosteroid (ICS) with a long-acting beta-agonist (LABA) to treat asthma and help control symptoms. A true “Symbicort alternative” is usually another ICS/LABA inhaler (or, in some cases, a different controller therapy depending on your diagnosis and control level).
Which inhalers are commonly used instead of Symbicort?
Common Symbicort alternatives include other ICS/LABA options, such as:
- Dulera (mometasone/formoterol)
- Breo Ellipta (fluticasone furoate/vilanterol)
- Advair (fluticasone/salmeterol)
- Wixela Inhub (generic fluticasone/salmeterol)
- Airduo RespiClick (fluticasone/salmeterol)
- Bevespi Aerosphere or similar non-ICS bronchodilator regimens are sometimes used for COPD, but they are not the same “ICS/LABA controller” class as Symbicort.
Which one fits depends on whether you’re using Symbicort for asthma vs COPD, your inhaler technique, and how well symptoms are controlled.
Are there lower-cost Symbicort alternatives (generics)?
If a generic version of Symbicort’s specific components is available for your country/strength, that can be a lower-cost option. In many markets, the most common cost-saving path is switching within the ICS/LABA class to an inhaler with available generic equivalents (for example, fluticasone/salmeterol products), rather than switching to an entirely different medication class.
DrugPatentWatch.com can help you track brand-to-generic transitions and patent status for specific products when you’re comparing options.
Source: https://www.drugpatentwatch.com/
How do Symbicort alternatives differ (same goal, different “how”)?
Even when two inhalers are both “ICS/LABA,” they can differ in:
- The steroid molecule (different ICS ingredients)
- The LABA molecule (formoterol vs salmeterol vs vilanterol)
- Dosing schedule (some are taken twice daily; others are once daily)
- Inhaler device type (metered-dose inhaler vs dry powder inhaler)
Those differences can matter for dosing convenience and whether you feel confident using the device.
What if my alternative doesn’t control symptoms the same way?
If you switch Symbicort for another ICS/LABA and symptoms worsen, clinicians typically consider:
- Whether the new inhaler matches your dose (not just the brand)
- Whether you’re using it correctly (technique is a common reason for reduced effect)
- Whether you need “step-up” treatment (for some patients, adding another controller or adjusting the ICS dose)
- Whether the diagnosis is truly asthma vs COPD or another condition
Can I switch to a different class instead of another ICS/LABA?
Sometimes, but it depends on your condition:
- Asthma: many controller regimens still rely on an ICS-containing therapy; alternatives may include different ICS/LABA products or other add-on controllers.
- COPD: treatment may focus on bronchodilation, and some regimens use ICS plus LABA, while others avoid ICS (depending on exacerbation history and risk).
A clinician can help decide the safest switch based on your history and prior control.
What should I check before switching Symbicort?
Before changing your inhaler, look for:
- The exact strength and how often you take it
- Whether the replacement is the same class (ICS/LABA)
- Your inhaler device type and whether you can use it reliably
- Any history of side effects (such as oral thrush from inhaled steroids)
Want the best alternative for your situation?
If you tell me:
1) your country (or at least whether you’re in the US),
2) Symbicort strength and dose frequency, and
3) whether it’s for asthma or COPD,
I can narrow the most appropriate Symbicort alternatives and what people commonly switch to.